# Tedizolid Prolonged Treatment for Prosthetic Joint Infections

> **NCT03378427** · NA · COMPLETED · sponsor: **Tourcoing Hospital** · enrollment: 35 (actual)

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **DRUG:** Tedizolid Phosphate 200 MG [Sivextro]

## Key facts

- **NCT ID:** NCT03378427
- **Lead sponsor:** Tourcoing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2020-10-22
- **Final completion:** 2021-08-22
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378427, "Tedizolid Prolonged Treatment for Prosthetic Joint Infections". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03378427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*